NDC 55150-328 – Naloxone Hydrochloride
Naloxone Hydrochloride .4 mg/mL · Injection, Solution · Intramuscular, Intravenous, Subcutaneous
Product NDC55150-328
Product details
- Brand name
- Naloxone Hydrochloride
- Generic name
- Naloxone Hydrochloride
- Labeler
- Eugia US LLC
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous, Subcutaneous
- Marketing category
- ANDA · ANDA212456
- Marketed since
- November 4, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Opioid Antagonist
Active ingredients
- Naloxone Hydrochloride .4 mg/mL
Uses, dosage, side effects and warnings for Naloxone Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 55150-328-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (55150-328-10) / 10 mL in 1 VIAL, MULTI-DOSE | Nov 4, 2019 |
| 55150-328-25 | 25 VIAL, MULTI-DOSE in 1 CARTON (55150-328-25) / 10 mL in 1 VIAL, MULTI-DOSE | Nov 4, 2019 |
Other Naloxone Hydrochloride products
- 50090-5427 Naloxone Hydrochloride .4 mg/mL · Injection, Solution · A-S Medication Solutions
- 50090-6491 Naloxone Hydrochloride .4 mg/mL · Injection, Solution · A-S Medication Solutions
- 36000-308 Naloxone Hydrochloride .4 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 36000-310 Naloxone Hydrochloride .4 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 43066-142 Naloxone Hydrochloride 1 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 54288-124 Naloxone Hydrochloride 1 mg/mL · Injection, Solution · BPI Labs LLC
- 55150-327 Naloxone Hydrochloride .4 mg/mL · Injection, Solution · Eugia US LLC
- 55150-345 Naloxone Hydrochloride 1 mg/mL · Injection, Solution · Eugia US LLC
- 76045-114 Naloxone Hydrochloride .4 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 76045-112 Naloxone Hydrochloride 1 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 0404-9773 Naloxone Hydrochloride .4 mg/mL · Injection, Solution · Henry Schein, Inc.
- 0404-9920 Naloxone Hydrochloride .4 mg/mL · Injection, Solution · Henry Schein, Inc.